1 year return (CAGR)
193.99%
Aclaris Therapeutics Inc Exchange (NASDAQ, USD)
ACRS
5.15
+0.12 (+2.28%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-10.08%
5 year return (CAGR)
-20.98%
10 year return (CAGR)
-13.86%
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
791.93M
Price/Sales
96.35
Ent value
827.88M
Price/Book
6.36
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-15.09%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 5.24 |
| Daily high | 5.44 |
| Daily low | 5.14 |
| Daily Volume | 2.49M |
| All-time high | 32.99 |
| 1y analyst estimate | 10.18 |
| Beta | 0.80 |
| EPS (TTM) | -0.53 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 3 Mar 2026 |
Downside potential
Loading...
Downside potential data
| ACRS | S&P500 | |
| Current price drop from All-time high | -84.39% | -0.84% |
| Highest price drop | -98.04% | -56.47% |
| Date of highest drop | 13 Nov 2023 | 9 Mar 2009 |
| Avg drop from high | -64.16% | -10.68% |
| Avg time to new high | 110 days | 12 days |
| Max time to new high | 2374 days | 1805 days |
News
